- Market Capitalization, $K 38,957
- Shares Outstanding, K 11,201
- Annual Sales, $ 1,560 K
- Annual Income, $ -14,520 K
- 60-Month Beta N/A
- Price/Sales 25.59
- Price/Cash Flow N/A
- Price/Book 11.47
|Period||Period Low||Period High||Performance|
| || |
-0.59 (-14.94%)since 09/29/20
| || |
-3.82 (-53.20%)since 07/29/20
, /PRNewswire/ -- The global cancer diagnostics market is of the more innovative segments of the global diagnostics industry today. Cancer is one of the leading causes of death across the world, and its...
, /PRNewswire/ --
Companies in the news are: IMAB, LMPX, DPW, ANPC
, /PRNewswire/ -- The diagnostics industry is a large and varied market, with new and innovative technology constantly being introduced. There are also various types of diagnostic methods including In...
, /PRNewswire/ -- Cancer is among the leading causes of death in the world as countries are burdened by a lack of access to adequate healthcare. In particular, the top three diagnosed cancers accounted...
, /PRNewswire/ -- Infectious diseases are caused by pathogenic microorganisms such as bacteria, viruses, fungi and parasites, and can be transmitted by direct or indirect contact. Globally, infectious...
, /PRNewswire/ -- As healthcare systems come under severe pressure from the pandemic, significant changes to their infrastructure are needed and being implemented. In particular, effective and mass testing...
, /PRNewswire/ -- As the pandemic continues to spread throughout the U.S., the need for testing is on the rise as well. But many states and regions are experiencing a shortage of tests, which is a serious...
, /PRNewswire/ -- The diagnostics industry is large and diverse, with new innovative solutions constantly changing its landscape. Generally, diagnostic tests are conducted in laboratories, private or...
AnPac Bio-Medical Science Co., Ltd. ("AnPac Bio," the "Company" or "we") (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection,...